Skip to content

Clinical trials

Completed Phase 1/2 Carcinoma, Squamous Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Squamous Cell Phase: Phase 1/2 Status: Completed Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20082
20103
20131
20161
20173
20181
20194
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Advaxis, Inc.1
BPGbio1
Cascadian Therapeutics Inc.1
Centre hospitalier de l'Université de Montréal (CHUM)1
Dana-Farber Cancer Institute1
Federation Francophone de Cancerologie Digestive1
Hookipa Biotech GmbH1
Intensity Therapeutics, Inc.1
M.D. Anderson Cancer Center1
NanoCarrier Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Squamous Cell18
Head and Neck Neoplasms6
Carcinoma4
Carcinoma, Non-Small-Cell Lung4
Squamous Cell Carcinoma of Head and Neck4
Colorectal Neoplasms3
Lung Neoplasms3
Neoplasms2
Neoplasms, Squamous Cell2
Pancreatic Neoplasms2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.